deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03552393

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.

An Open-Label, Single-Arm, Multicenter Study to Ascertain the Optimal Starting Dose of MIRCERA® Given Subcutaneously for the Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.

Sponsor: Hoffmann-La Roche

Conditions Anemia Renal Insufficiency, Chronic
Interventions Mircera
Updated 32 times since 2018 Last updated: Mar 3, 2022 Started: Aug 3, 2018 Primary completion: Jul 19, 2021 Completion: Jul 19, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Anemia and Renal Insufficiency, Chronic and is currently completed. Hoffmann-La Roche leads this study, which shows 32 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

32 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE2

  5. Dec 2021 — Apr 2022 [monthly]

    Completed PHASE2

▶ Show 27 earlier versions

  1. Nov 2021 — Dec 2021 [monthly]

    Completed PHASE2

  2. Oct 2021 — Nov 2021 [monthly]

    Completed PHASE2

  3. Sep 2021 — Oct 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Jun 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE2

  5. May 2021 — Jun 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Apr 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE2

  7. Mar 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE2

  8. Feb 2021 — Mar 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  9. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  10. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  11. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  12. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  13. Jul 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  14. May 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  15. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE2

  16. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

  17. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE2

  18. Aug 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  19. Jun 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  20. May 2019 — Jun 2019 [monthly]

    Recruiting PHASE2

  21. Mar 2019 — May 2019 [monthly]

    Recruiting PHASE2

  22. Jan 2019 — Mar 2019 [monthly]

    Recruiting PHASE2

  23. Nov 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  24. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  25. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE2

  26. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE2

  27. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hoffmann-La Roche
Data source: Hoffmann-La Roche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Barcelona, Spain , Birmingham, United States , Budapest, Hungary , Dallas, United States , Debrecen, Hungary , Gdansk, Poland , Greenville, United States , Kansas City, United States , Krakow, Poland and 12 more locations